SenesTech (NASDAQ:SNES) will be announcing its earnings results after the market closes on Wednesday, May 15th.
SenesTech (NASDAQ:SNES) last posted its quarterly earnings results on Thursday, March 28th. The company reported ($0.10) EPS for the quarter, hitting analysts’ consensus estimates of ($0.10). The company had revenue of $0.14 million for the quarter, compared to analysts’ expectations of $0.58 million. SenesTech had a negative net margin of 4,009.43% and a negative return on equity of 182.12%.
NASDAQ:SNES opened at $1.76 on Friday. The company has a current ratio of 5.74, a quick ratio of 4.65 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $43.13 million, a P/E ratio of -2.79 and a beta of 1.67. SenesTech has a 12 month low of $0.30 and a 12 month high of $2.37.
Separately, Zacks Investment Research raised shares of SenesTech from a “sell” rating to a “hold” rating in a report on Wednesday, January 16th.
ILLEGAL ACTIVITY WARNING: This piece was reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2019/05/10/senestech-snes-scheduled-to-post-quarterly-earnings-on-wednesday.html.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.
Read More: What is a bull market?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.